Ca2+ antagonists and vascular disease.
Vanhoutte
P M
PM
Department of Physiology and Biophysics, Mayo Clinic, Rochester, Minnesota 55905.
D000818:Animals; D001688:Biological Products / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009569:Nitric Oxide; D014652:Vascular Diseases / Q000188:drug therapy*
D001688:Biological Products; D002121:Calcium Channel Blockers; D009569:Nitric Oxide